Patents Assigned to Biocodex, Inc
  • Publication number: 20140031539
    Abstract: The present invention relates to certain purines, which act as topoisomerase II catalytic inhibitors. These compounds are useful in combination with topoisomerase II poisons, such as anthracyclines and epipodophyllotoxins, in the treatment of proliferative conditions (e.g., cancer). These compounds are useful in the treatment of tissue damage associated with extravasation of a topoisomerase II poison, such as an anthracycline or an epipodophyllotoxin.
    Type: Application
    Filed: July 3, 2013
    Publication date: January 30, 2014
    Applicant: Biocodex, Inc
    Inventors: Lars Hollund JENSEN, Maxwell SEHESTED